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Emerging hypotheses will be possible for objectives 1-3 and maybe 4. Hypotheses may emerge regarding objective 5 but given the small sample size the authors are unlikely to reach data saturation which in turn will impact on the generalisability of findings. No mention is made of data saturation as a guide to determine sample size -if data saturation is not being used then this a limitation that needs acknowledging (see also point 7 below). 6. Methods and Analysis: p7 line 8-10 Consider using the term mixed methods and reflecting on how the integration of data from multiple sources may lead to insights that are greater than the sum of the parts (see Greene J, Qualitative Health Research 2015, Vol. 25(6) 746 750. 7. P7 lines 40-56. A sample of 10 patients and 5 health professionals involves very small numbers, even more so as you are 1) proposing to sample patients at different points on the AS trajectory (see statement on P6 lines 20-27) and patient perceptions of risk of PCa may evolve with time on AS; and 2) proposing to sample urologists, surgeons, specialist nurses as these groups may have different perceptions of PCa risk. Given the very small sample, I felt you were unlikely to reach data saturation -no mention is made of this, so perhaps it can be added to the limitations. Moreover, the sampling strategy used is consecutive sampling of patients rather than maximum variation sampling -the latter would be more effective in sampling the maximum range of views and experiences or points on the AS trajectory and thus maximising the generalisability of your findings. I am not clear why the goal to reduce bias (relevant to quantitative data collection e.g. survey data) is stated in a study that is predominantly qualitative in its analytic approach. 8. P9 lines 5 "The timing of discussions will be noted" -I wasn"t clear whether this meant the timing in the context of the patient journey (e.g. just starting on AS vs <5 yrs on AS) or whether it referred to the timing or time spent on various topics within the consultation. 9. Data analysis p10 -interesting that interviews will be transcribed but observational data not. I understand practicalities may preclude transcription but perhaps explain why it is felt that analysis of audio recordings will be sufficient. 10. Data analysis p10-11 You state that you will use thematic analysis to analyse interview data -perhaps you intend to use the principles of thematic analysis in analysing observed consultation data and developing your preliminary classification but this is not clear in the Abstract or the Data analysis. On p5 lines 43-47 you state that "We aim to identify definitions of risk, from men"s own experiences of AS, rather than from a pre-determined, or clinicallydriven assumption of what risk means for those being assessed for AS and those undertaking the treatment." This implies thematic analysis based on the principles of constant comparison yet it is not stated for the analysis of observational data -I was not clear from the current description to what extent the classification derived from analysis of observation data was to be pre-determined and to what extent allowed to emerge from your data. Your analysis is likely to be more powerful if you employ a bottom-up approach to both observational and interview data rather than drawing conclusions, derived from observational data analysis and applying them to interview data, without allowing new insights to emerge from the interview data themselves. Differences in views between patients and health professionals (via interviews or observations) and evidence of miscommunication (via interviews or observations) will be particularly informative.
11. This paper could usefully make reference to recent work in prostate cancer that is relevant to both the subject matter and methods of this study -and in which one of the authors of the current paper has previous involvement e.g. Donovan JL, Hamdy FC, Lane JA, et al. (2016) Perhaps the most important limitation of the planned research is the sample size, which is a minimum of 10 patients. The study will not employ any formal statistics and so statistical power is not an issue. Still, I wonder what kinds of conclusions can be drawn about the experiences of PCa patients from just 10 patients and 5 healthcare professionals. This study seems like pilot data for a larger future study, which certainly is not a bad thing, but I worry that it will not be possible to draw broader conclusions from the study, thus limiting its potential impact.
The plan for the semi-structured interviews seemed a bit vague. For example, the research plans to assess "perceptions of risk and risk status", but there are many different kinds of risks in this context and it would be good to be reassured that the authors had thought of these in advance, and whether patients" thoughts on the different kinds of risks will be elicited. In particular, there is the risk of cancer with and without active treatment, as well as the risk of different kinds of side effects (physical and emotional) from different types of treatments, including AS. Moreover, there are at least two different components of each of these risks: likelihood perceptions, and severity perceptions.
I also wondered whether the authors had thought deeply about observing body language in the patient-provider interactions. The plan seemed vague, e.g. "the researcher will note body language and non-verbal exchanges between the patient and the healthcare professional". What kinds of body language will be noted? Is there are theoretical perspective or background that the authors will be working from when making these observations?
Exclusion criteria: The study protocol states that "Men who the dedicated clinician or members of the clinical team deem unsuitable for participation due to physical, cognitive, or emotional risk…" This is a broad and subjective list of factors and might further limit the generalizability of the study observations.
Inclusion criteria: Men will be included only if they are considered a candidate for AS. I wondered who is considered a candidate for AS in this population of patients? In my experience there is a surprising amount of disagreement about eligibility for AS among clinicians and so I wondered how this study will define it.
How will this study address the Hawthorne effect? That is, will the consulting providers know that they are being recorded and know the goals of the study, which might change how they communicate risks to patients? Or, will they be kept blind to certain aspects of the study purpose?
Thank you for the opportunity to review this protocol, which addresses the very important issue of how risk for prostate cancer is perceived and experienced by patients following an active surveillance protocol, how health professionals supporting these patients perceive the risks and how risks are communicated between health professionals and patients. This protocol is clearly written and deserves publication. My comments are intended to increase the clarity of the methods outlined.
Response: We thank the reviewer for her supportive comments.
Comment 1. The abstract does not state how many participants the study proposes to recruit, Response: The anticipated number of participants has been added to the abstract. Mention of thematic analysis has also been added to the abstract.
Comment: nor does it state the theoretical underpinnings of the analysis (see also point 10 below)
Response: We have added a new section in to the manuscript to state the theoretical underpinnings of the analysis, based on the applied thematic analysis approach of Guest, MacQueen and Namey (2012).
Comment 2. Introduction lines p4 35-38: I wonder whether the purpose of AS is in fact to offer patients the choice of avoiding radical treatments (and their side effects) whilst enabling timely curative treatments if cancer progression is indicated (see Simpkin et al. 2015) . The challenge is that we do not currently know which cancers will progress. Patients therefore have to accept a degree of uncertainty as the current evidence does not allow us to remove all uncertainty.
Response: Thank you for these thoughtful comments. These ideas have been incorporated into the manuscript. We have amended the introduction to reflect these issues. Response: Thank you for bringing our attention to this reference. We have included it in the introduction section.
Comment 4. Introduction p6 lines 12-13 "Together these findings suggest that patients" perceptions of risk are developed through communication with clinicians". This statement seems to contradict the earlier statement on p5 lines 38-42 which reads "However, perceptions and understandings of uncertainties around such an event are highly individualised, influenced not only by controllability of clinical outcomes, but also gender issues and social factors.
Response: We have amended the manuscript to indicate that patients" perceptions of risk are more complex than we have described, and are influenced both by what people bring to a consultation, and by the conversations that come to the fore during the consultation and the impact of both.
Comment: I agree with the statement p5 lines 38-42 -perhaps "developed" in the statement p6 lines 12-13 should read "shaped by" so as to acknowledge that whilst very important, communication with clinicians is not the only determining factor".
Response: The manuscript has been amended as suggested.
Comment 5. Study objectives: I agree that these objectives are all important however I am not sure they can all be achieved from a predominantly qualitative investigation with a sample of only 10 patients and 5 health professionals with various professional backgrounds.
Response: We are hoping to derive a hypothesis from the data to enrich our understanding of the topic, though we recognise that this will not necessarily be findings that can be considered generalisable to a wider population. The derived hypothesis could be applied, however, following this work to a larger study that will lead to data findings that are more applicable to a wider population group.
Comment: Emerging hypotheses will be possible for objectives 1-3 and maybe 4. Hypotheses may emerge regarding objective 5 but given the small sample size the authors are unlikely to reach data saturation which in turn will impact on the generalisability of findings. No mention is made of data saturation as a guide to determine sample size -if data saturation is not being used then this a limitation that needs acknowledging (see also point 7 below).
Response: Saturation will support the determination of the final sample size, as the reviewer points out. However, based on our prior work, we anticipate that 10 patients will result in data saturation (see similar work in breast cancer (Khanom et al 2017)). We have amended the text to indicate this.
Comment 6. Methods and Analysis: p7 line 8-10 Consider using the term mixed methods and reflecting on how the integration of data from multiple sources may lead to insights that are greater than the sum of the parts (see Greene J, Qualitative Health Research 2015, Vol. 25(6) 746 750.
Response: This study uses a multi-method (also known as intra-method) data collection approachno quantitative data is going to be collected. Insights from the interviews and observations will be considered equally and in corroboration. Rather than being used to undercut one another, datasets will embellish one another, adding to our understanding and adding detail and richness to data presentations.
Comment 7. P7 lines 40-56. A sample of 10 patients and 5 health professionals involves very small numbers, even more so as you are 1) proposing to sample patients at different points on the AS trajectory (see statement on P6 lines 20-27) and patient perceptions of risk of PCa may evolve with time on AS; and 2) proposing to sample urologists, surgeons, specialist nurses as these groups may have different perceptions of PCa risk.
Response: This work is considered a proof of concept study, testing out the multi-method approach in PCa in Australia for the first time. We have emphasised this now in the methods section.
Comment: Given the very small sample, I felt you were unlikely to reach data saturation -no mention is made of this, so perhaps it can be added to the limitations.
Response: Despite the small sample size, patients attending the Urology clinic at the University hospital site in question represent a wide demographic: they come from both metropolitan and rural areas, and they cover a range of ages, ethnicities and socioeconomic backgrounds.
Comment: Moreover, the sampling strategy used is consecutive sampling of patients rather than maximum variation sampling -the latter would be more effective in sampling the maximum range of views and experiences or points on the AS trajectory and thus maximising the generalisability of your findings.
Response: With the wide range of patients accessing services in this particular University hospital site, we would, with respect, suggest that timeframe sampling is a suitable approach in this instance. It ensures minimum researcher influence, with no influence of participant selection, which is wholly dependent on the predetermined timeframe for recruitment.
Comment; I am not clear why the goal to reduce bias (relevant to quantitative data collection e.g. survey data) is stated in a study that is predominantly qualitative in its analytic approach Response: We thank the reviewer for highlighting this error. The phrase has been removed.
Comment 8. P9 lines 5 "The timing of discussions will be noted" -I wasn"t clear whether this meant the timing in the context of the patient journey (e.g. just starting on AS vs <5 yrs on AS) or whether it referred to the timing or time spent on various topics within the consultation.
Response: We have clarified this statement to align with the reviewer"s suggestion.
Comment 9. Data analysis p10 -interesting that interviews will be transcribed but observational data not. I understand practicalities may preclude transcription but perhaps explain why it is felt that analysis of audio recordings will be sufficient.
Response:The strength of the observation data is in what can be seen and noted by the researcher working in-situ, such as visual cues and body language. Audio recordings will provide a detailed record of the "talk" of the consultation, but field notes will document the visual and non-verbal elements and the researcher"s views of the interaction, which we consider vital to understanding the complete experience. This point has been added to the manuscript.
Comment 10. Data analysis p10-11 You state that you will use thematic analysis to analyse interview data -perhaps you intend to use the principles of thematic analysis in analysing observed consultation data and developing your preliminary classification but this is not clear in the Abstract or the Data analysis.
Response: Thank you for alerting us to this omission. It has been rectified.
Comment: On p5 lines 43-47 you state that "We aim to identify definitions of risk, from men"s own experiences of AS, rather than from a pre-determined, or clinically-driven assumption of what risk means for those being assessed for AS and those undertaking the treatment." This implies thematic analysis based on the principles of constant comparison yet it is not stated for the analysis of observational data -I was not clear from the current description to what extent the classification derived from analysis of observation data was to be pre-determined and to what extent allowed to emerge from your data.
Response: Analysis of the observation data will not be pre-determined and as for the interview data, analysis will fully emerge from the collected data over time. As stated by the reviewer, this will be done thematically, in this case through an applied thematic analysis technique. The analysis section has been amended to clarify this issue.
Comment: Your analysis is likely to be more powerful if you employ a bottom-up approach to both observational and interview data rather than drawing conclusions, derived from observational data analysis and applying them to interview data, without allowing new insights to emerge from the interview data themselves. Differences in views between patients and health professionals (via interviews or observations) and evidence of miscommunication (via interviews or observations) will be particularly informative
Response: We agree with the reviewer"s suggestion, and have added the following information to the text: "In line with applied thematic analysis, we intend to use a "bottom-up" approach to both the observational and interview data, with conclusions derived from these datasets, and new insights emerging as time progresses. Once no new insights are forthcoming the applied thematic analysis framework is said to have reached a point of saturation, where no new categories are in evidence" (Robson C. Real World Research, 2nd Edn. 2002, Blackwell Publishers) .
Comment 11. This paper could usefully make reference to recent work in prostate cancer that is relevant to both the subject matter and methods of this study -and in which one of the authors of the current paper has previous involvement e.g. 
Reviewer: 2
Comment: The proposed research is an observational study of men diagnosed with early stage prostate cancer who are eligible for active surveillance. In general the research is very interesting; risk communication is especially important in early stage prostate cancer treatment and the incorporation of observing patient-provider interactions is sure to be revealing.
Response: We thank the reviewer for these acknowledgements Comment: Perhaps the most important limitation of the planned research is the sample size, which is a minimum of 10 patients. The study will not employ any formal statistics and so statistical power is not an issue. Still, I wonder what kinds of conclusions can be drawn about the experiences of PCa patients from just 10 patients and 5 healthcare professionals. This study seems like pilot data for a larger future study, which certainly is not a bad thing, but I worry that it will not be possible to draw broader conclusions from the study, thus limiting its potential impact.
Response: As the reviewer remarks, this is an early, proof of concept study. We have amended the manuscript and title to state this more explicitly.
Comment: The plan for the semi-structured interviews seemed a bit vague. For example, the research plans to assess "perceptions of risk and risk status", but there are many different kinds of risks in this context and it would be good to be reassured that the authors had thought of these in advance, and whether patients" thoughts on the different kinds of risks will be elicited. In particular, there is the risk of cancer with and without active treatment, as well as the risk of different kinds of side effects (physical and emotional) from different types of treatments, including AS. Moreover, there are at least two different components of each of these risks: likelihood perceptions, and severity perceptions.
Response: This section has been expanded to include the nature of risk perception, as suggested by the reviewer. Table 2 has been added to specify interview questions targeting risk perception.
Comment: I also wondered whether the authors had thought deeply about observing body language in the patient-provider interactions. The plan seemed vague, e.g. "the researcher will note body language and non-verbal exchanges between the patient and the healthcare professional". What kinds of body language will be noted?
Response: Thank you for this suggestion. Body language comprises one part of an extensive observational checklist, alongside consideration of the conversations held, the environment and setting within which consultations take place, and emotions expressed. This has been clarified in the text. Thus, body language and dialogue are considered together alongside fieldnotes, and not analysed separately.
Comment: Is there are theoretical perspective or background that the authors will be working from when making these observations?
Comment: Exclusion criteria; The study protocol states that "Men who the dedicated clinician or members of the clinical team deem unsuitable for participation due to physical, cognitive, or emotional risk…" This is a broad and subjective list of factors and might further limit the generalizability of the study observations.
Response: Our intention was to safeguard the rights of patients not to participate in the study. By flagging these broad criteria with the clinical team, we will be able to anticipate patients who may not wish to be involved in all, or any, aspect of the study. As explained above, ours is a small study and we are not aiming for generalizability at this stage.
Comment: Inclusion criteria: Men will be included only if they are considered a candidate for AS. I wondered who is considered a candidate for AS in this population of patients? In my experience there is a surprising amount of disagreement about eligibility for AS among clinicians and so I wondered how this study will define it.
Response: We agree that there is a considerable degree of debate on the subject. However, the system below (based on D Amico classification from 2012) will enable consistent identification of potential participants. All defined by biopsy results: Our inclusion criteria, devised by medical experts within the study team, are:
• Gleason sum 6 or less (Gleason 3+3=6; or Gleason 3+4 =7 if low volume on biopsies (1 positive biopsy))
• PSA 10mg/ml or less • T1c-T2a disease (T1c (impalpable) or T2a (unilateral palpable) Additionally, inclusion may also be defined by volume of cancer on biopsy. The manuscript has been amended with this information.
Comment: How will this study address the Hawthorne effect? That is, will the consulting providers know that they are being recorded and know the goals of the study, which might change how they communicate risks to patients? Or, will they be kept blind to certain aspects of the study purpose?
Response: Consultants in our study will be observed on many occasions throughout the study, at different times of day, and with different patients facing different clinical and personal considerations. We believe that this repeated exposure and variability will reduce any possibility of the Hawthorne effect being in evidence.
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GENERAL COMMENTS
All my comments have been addressed. Addition of the two tables is also very helpful and will make this study easier to replicate.
